STRAUMANN EMDOGAIN

Biologic Material, Dental

FDA Premarket Approval P930021 S014

This medical device record is a pma supplement. A supplement may have changed the device description/function or indication from that approved in the original pma. Be sure to look at the original pma record for more information.

Pre-market Approval Supplement Details

Approval for adding the use of biphasic calcium phosphate (haij3-tcp) bone graft materials with straumann emdogain, adding the use of collagen and other graft materials with straumann emdogain and changing the name of a contract manufacturer, in name only, from sverige, scan ab to hkscan sweden ab. The device, as modified, will be marketed under the trade name straumann emdogain and is indicated for use as an adjunct to periodontal surgery as a topical application onto exposed root surfaces. Emdogain is indicated for the treatment of the following conditions:1) intrabony defects due to moderate or severe periodontitis;2) mandibular degree ii furcations with minimal interproximal bone loss; 3) gingival recession defects in conjunction with surgical coverage procedures such asthe coronally advanced flap technique; and4) emdogain is also indicated for use in a minimally invasive surgical technique in esthetic zones to optimize tissue height for intrabony defects only. In cases of wide defects or where soft tissue support is desired, straumann emdogain can be used in conjunction with a bone graft material. For further information on the use of emdogain with bone graft materials, please refer to, for straumann emdogain in conjunction with bone graft material in wide defects in the clinical procedure section of the draft instructions.

DeviceSTRAUMANN EMDOGAIN
Classification NameBiologic Material, Dental
Generic NameBiologic Material, Dental
ApplicantTHE STRAUMANN COMPANY
Date Received2015-03-02
Decision Date2015-08-26
PMAP930021
SupplementS014
Product CodeNQA
Advisory CommitteeDental
Supplement TypeNormal 180 Day Track
Supplement ReasonChange Design/components/specifications/material
Expedited ReviewNo
Combination Product Yes
Applicant Address THE STRAUMANN COMPANY 60 Minuteman Road andover, MA 01810

Supplemental Filings

Supplement NumberDateSupplement Type
P930021Original Filing
S030 2023-01-04 30-day Notice
S029 2022-10-17 30-day Notice
S028
S027 2021-01-29 30-day Notice
S026 2020-08-12 30-day Notice
S025 2019-08-09 30-day Notice
S024
S023 2018-11-02 135 Review Track For 30-day Notice
S022 2018-10-24 135 Review Track For 30-day Notice
S021 2018-10-22 135 Review Track For 30-day Notice
S020 2018-05-10 30-day Notice
S019 2018-04-13 135 Review Track For 30-day Notice
S018 2017-12-15 135 Review Track For 30-day Notice
S017 2016-09-09 135 Review Track For 30-day Notice
S016 2016-04-06 Normal 180 Day Track
S015 2015-06-29 30-day Notice
S014 2015-03-02 Normal 180 Day Track
S013 2012-09-19 Normal 180 Day Track No User Fee
S012 2009-01-12 Normal 180 Day Track No User Fee
S011 2008-03-27 Normal 180 Day Track
S010 2007-10-09 Real-time Process
S009 2006-04-11 Special (immediate Track)
S008 2002-09-13 Normal 180 Day Track
S007 2002-07-01 Normal 180 Day Track
S006 2002-06-17 Normal 180 Day Track
S005 2000-07-26 Normal 180 Day Track
S004 2000-03-09 Real-time Process
S003 1999-05-20 Normal 180 Day Track
S002 1999-01-26 Normal 180 Day Track
S001 1998-01-05 Normal 180 Day Track

NIH GUDID Devices

Device IDPMASupp
07630031700100 P930021 013
07630031700025 P930021 013
07630031700087 P930021 013
07630031730046 P930021 020
07630031729989 P930021 020
07630031730015 P930021 020
07630031730022 P930021 020
07630031730039 P930021 020
07630031747389 P930021 024
07630031747372 P930021 024

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.